Ophthalmology and Visual Impairment Studies
Ophthalmology and Visual Impairment Studies is a research topic within Epidemiology. Science Explorer counts 42k research works in it since 1950. 9.9% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the global epidemiology of myopia and visual impairment, including the prevalence, risk factors, progression, and treatment of myopia, refractive errors, and related conditions. It also explores the impact of environmental factors, genetic influences, and interventions such as orthokeratology and atropine therapy.
- Myopia
- Visual Impairment
- Epidemiology
- Refractive Error
- Global Prevalence
- Childhood Myopia
- Uncorrected Refractive Errors
- Amblyopia
- Ocular Aberrations
- Orthokeratology
- Research works
- 42k fractional, since 1950
- In the world top 10%
- 4.2k per year above
- Top-10% rate
- 9.9% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +23% the tick is no change
- Largest producer
China
28% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Ophthalmology and Visual Impairment Studies research?
By volume, China and the United States publish the most (2k and 1.7k works in 2022-now).
By volume, 2022-now
- 1
China 2k works
- 2
United States 1.7k works
- 3
India 707 works
- 4
United Kingdom 593 works
- 5
Spain 457 works
- 6
Germany 413 works
- 7
Japan 347 works
- 8
Australia 285 works
- 9
South Korea 267 works
- 10
Türkiye 256 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Ophthalmology and Visual Impairment Studies research?
By volume in 2022-now, Wenzhou Medical University publishes the most Ophthalmology and Visual Impairment Studies research, followed by Sun Yat-sen University and Fudan University.
By volume, 2022-now
- 1
Wenzhou Medical University
China 134 works
- 2
Sun Yat-sen University
China 109 works
- 3
Fudan University
China 96 works
- 4
Capital Medical University
China 93 works
- 5
Harvard University
United States 76 works
- 6
Tianjin Medical University
China 74 works
- 7
University College London
United Kingdom 67 works
- 8
Peking University
China 60 works
- 9
He Eye Hospital
China 57 works
- 10
All India Institute of Medical Sciences
India 55 works
Who are the leading researchers in Ophthalmology and Visual Impairment Studies?
The most-cited researchers publishing on Ophthalmology and Visual Impairment Studies include Christopher J L Murray, Theo Vos and George Davey Smith.
- 1
Christopher J L Murray
United States 583k citations
- 2
Theo Vos
United States 439k citations
- 3
George Davey Smith
United Kingdom 435k citations
- 4
Ali H. Mokdad
United States 429k citations
- 5
Walter Churchill Willett
United States 411k citations
- 6
Mark J. Daly
United States 403k citations
- 7
Jost Bruno Jonas
Germany 350k citations
- 8
Cyrus Cooper
United Kingdom 342k citations
- 9
Jun Wang
China 340k citations
- 10
Gordon Henry Guyatt
Canada 315k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Ophthalmology and Visual Impairment Studies research done?
The largest centres of Ophthalmology and Visual Impairment Studies research in 2022-now are Beijing (China), London (United Kingdom), Shanghai (China) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in East Melbourne, Alicante and Wenzhou.
Largest cities, 2022-now
Where it is the local speciality
- East MelbourneAU · 23.1 works80×
- AlicanteES · 52.1 works16×
- WenzhouCN · 136.2 works15×
Location quotient: how much more of its research is in Ophthalmology and Visual Impairment Studies than the world average.
Where is the best place to study Ophthalmology and Visual Impairment Studies?
Among universities, judged by research, Chinese University of Hong Kong, Sun Yat-sen University and The University of Melbourne score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Ophthalmology and Visual Impairment Studies, country by countryIs Ophthalmology and Visual Impairment Studies research growing?
Output in 2022-2025 was 23% higher than in 2018-2021, peaking in 2026. The fastest-growing topics are Ophthalmology and Visual Impairment Studies.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Ophthalmology and Visual Impairment Studies as a percentage of every work published that year, 0.036% in 2024.
Fractional works of Ophthalmology and Visual Impairment Studies over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Ophthalmology and Visual Impairment Studies. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.